Vaccination anti-pneumococcique chez l’adulte : comment améliorer la couverture vaccinale ?-Reference-Cited by-同舟云学术

Vaccination anti-pneumococcique chez l’adulte : comment améliorer la couverture vaccinale ?

Published:2014-06 Issue:2 Volume:16 Page:89-98
ISSN:2210-6545
Container-title:Journal des Anti-infectieux
language:fr
Short-container-title:Journal des Anti-infectieux

Author:

Goulenok T.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases

Reference80 articles.

1. MMWR ACIP. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report. 2012 October 12, 2012; 61.(N0 40).

2. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project;Johnson;PLoS Med,2010

3. WHO. Estimated Hib and pneumococcal deaths for children under 5 years of age, 2008. 2012 [cited; available from: http://www.who.int/immunization/monitoring_surveillance/burden/estimates/Pneumo_hib/en/index.html.

4. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia;Naucler;Thorax,2013

5. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults;Kyaw;J Infect Dis,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies implemented to address vaccine hesitancy in France: A review article;Human Vaccines & Immunotherapeutics;2018-06-14

2. Couverture vaccinale antigrippale et antipneumococcique dans un service de médecine interne;La Revue de Médecine Interne;2018-06

3. Couverture vaccinale anti-pneumococcique chez des patients à risque hospitalisés : évaluation et propositions d’amélioration;Annales Pharmaceutiques Françaises;2016-05